105 related articles for article (PubMed ID: 7799395)
1. N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
Davidsen SK; Summers JB; Albert DH; Holms JH; Heyman HR; Magoc TJ; Conway RG; Rhein DA; Carter GW
J Med Chem; 1994 Dec; 37(26):4423-9. PubMed ID: 7799395
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
Albert DH; Magoc TJ; Menacherry SD; Morgan DW; Sun E; Reyes AE; Kleinert HD; Carter GW; Summers JB
Inflamm Res; 1997 Jul; 46(7):272-7. PubMed ID: 9266276
[TBL] [Abstract][Full Text] [Related]
3. ABT-299, a potent antagonist of platelet activating factor.
Summers JB; Albert DH; Davidsen SK; Conway RG; Holms JH; Magoc TJ; Luo G; Tapang P; Rhein DA; Carter GW
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():475-7. PubMed ID: 7732895
[No Abstract] [Full Text] [Related]
4. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
Albert DH; Conway RG; Magoc TJ; Tapang P; Rhein DA; Luo G; Holms JH; Davidsen SK; Summers JB; Carter GW
J Pharmacol Exp Ther; 1996 Jun; 277(3):1595-606. PubMed ID: 8667228
[TBL] [Abstract][Full Text] [Related]
5. Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.
Girotra NN; Biftu T; Ponpipom MM; Acton JJ; Alberts AW; Bach TN; Ball RG; Bugianesi RL; Parsons WH; Chabala JC
J Med Chem; 1992 Sep; 35(19):3474-82. PubMed ID: 1404229
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist.
Albert DH; Magoc TJ; Kleinert HD; Sun E; Reyes AE; Carter GW; Summers JB
Adv Exp Med Biol; 1996; 416():381-7. PubMed ID: 9131177
[No Abstract] [Full Text] [Related]
7. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
[TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
[No Abstract] [Full Text] [Related]
9. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
10. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship.
Azzouz R; Peauger L; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Papamicaël C; Levacher V
Eur J Med Chem; 2018 Feb; 145():165-190. PubMed ID: 29324339
[TBL] [Abstract][Full Text] [Related]
11. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Trova MP; Wissner A; Carroll ML; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Kohler CA
J Med Chem; 1993 Mar; 36(5):580-90. PubMed ID: 8496938
[TBL] [Abstract][Full Text] [Related]
12. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
Prokai L; Prokai-Tatrai K; Zharikova AD; Nguyen V; Perjesi P; Stevens SM
J Med Chem; 2004 Nov; 47(24):6025-33. PubMed ID: 15537357
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
Grue-Sørensen G; Nielsen IM; Nielsen CK
J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.
Dosa PI; Ward T; Castro RE; Rodrigues CM; Steer CJ
ChemMedChem; 2013 Jun; 8(6):1002-11. PubMed ID: 23640741
[TBL] [Abstract][Full Text] [Related]
16. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055.
Gingrich DE; Reddy DR; Iqbal MA; Singh J; Aimone LD; Angeles TS; Albom M; Yang S; Ator MA; Meyer SL; Robinson C; Ruggeri BA; Dionne CA; Vaught JL; Mallamo JP; Hudkins RL
J Med Chem; 2003 Dec; 46(25):5375-88. PubMed ID: 14640546
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
[TBL] [Abstract][Full Text] [Related]
18. A pyridinium-substituted analog of the TRH-like tripeptide pGlu-Glu-Pro-NH2 and its prodrugs as central nervous system agents.
Prokai-Tatrai K; Teixido M; Nguyen V; Zharikova AD; Prokai L
Med Chem; 2005 Mar; 1(2):141-52. PubMed ID: 16787309
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
20. Some relationships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications.
Stella VJ; Martodihardjo S; Terada K; Rao VM
J Pharm Sci; 1998 Oct; 87(10):1235-41. PubMed ID: 9758683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
